Skip to main content
. 2015 Nov 6;6(4):137–144. doi: 10.4292/wjgpt.v6.i4.137

Figure 2.

Figure 2

Algorithm for selection of mesalazine formulations. Anti-TNF: Anti-tumour necrosis factor; AEs: Adverse events; MMX: Multi-matrix system; OD: Once daily; CRP: C-reactive protein.